イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text





Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Cell Culture & Characterization
Disease Models
In Vitro Assays
Toxicology
PromoCell
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron
Protein Sciences
Cocoon Bioscience

ブログ
Evolving Secondary Pharmacology: Functional, Dose-Response Safety Panels For Every Stage Of Discovery
9月 22, 2025
スポンサー:
スポンサー
ブログを読む
Pharmacology
In Vitro Assays
Discovery Chemistry
Toxicology
ICE Bioscience
In Vitro Assays
Bioimaging
Protein Sciences
Cell Culture & Characterization
Toxicology
No items found.

ブログ
Tumor Tissue Microarrays (TMAs): A High-Throughput Engine for Cancer Research
9月 17, 2025
スポンサー:
スポンサー
ブログを読む
Biomarkers
Disease Models
Bioimaging
Protein Sciences
DNA & RNA
Crown Bioscience
Antibodies
Protein Sciences
In Vitro Assays
Specifica
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.

ブログ
The Role of Recombinant Antibody Platforms in Advancing Therapeutic Development: Key Insights and Considerations for Production Success
8月 21, 2025
スポンサー:
スポンサー
ブログを読む
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron
Protein Sciences
No items found.

ブログ
Bridging the Gap: Image Software Quantification vs. Pathologist Scoring in Histopathology
7月 23, 2025
スポンサー:
スポンサー
ブログを読む
No items found.
Applied Pathology Systems

ブログ
Differentiating Between CROs, CDMOs and CMOs: How Each Plays a Role in Drug Development
7月 2, 2025
ブログを読む
Clinical Trials
Pharmacology
No items found.
Real-World Data (RWD)
Medical Communications
Real-World Evidence (RWE)
Joseph Zabinski
OM1
No items found.
Cell Culture & Characterization
Pharmacology
Sarah Thacker
Aurita Menezes
Katherine Dunnick
Lonza Group AG
Scientist.com
Cell Culture & Characterization
Disease Models
Pharmacology
Bert Blaauw
Aurora Scientific, Inc.
American Physiological Society
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Market Access
Matt McLoughlin
No items found.
Scientist.com
Chemical & Compound Analysis
Bioimaging
Venkateshkumar Prabhakaran
Harvard Bioscience, Inc.
No items found.
Real-World Evidence (RWE)
Market Access
Real-World Data (RWD)
Harlen Hays
Andy Klink
Sarah Lucht
Bruce A. Feinberg
Cardinal Health
No items found.
Pharmacology
Cell Culture & Characterization
Toxicology
Victoria Conlin
Danny Leung
STEMCELL Technologies Inc.
Scientist.com
Bioimaging
Pharmacology
Clinical Trials
Mukund Seshadri
FUJIFILM VisualSonics Inc.
No items found.

ポッドキャスト
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
7月 13, 2026
ポッドキャストを読む
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.





























.avif)








